Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Comparative Study From Sudan

PURPOSE: Chemotherapy-induced nausea and vomiting (CINV) is a distressing adverse effect. Neurokinin-1 receptor antagonist (NK1RA)–containing regimens are the standard regimens for CINV prophylaxis in patients with cancer receiving highly or moderately emetogenic chemotherapy (HEC or MEC). NK1RA age...

Descripción completa

Detalles Bibliográficos
Autores principales: Osman, Alaa A.M., Elhassan, Moawia M.A., AbdElrahim, Blala H.A., Ahmed, Fatima H.A., Yousif, Jihad B.H., Ahmed, Malak A.M., Abdelhafeez, Romisa H.A., Ahmed, Umsalama M.Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2018
Materias:
Original Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223527/
https://www.ncbi.nlm.nih.gov/pubmed/30241275
http://dx.doi.org/10.1200/JGO.17.00216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223527/
https://www.ncbi.nlm.nih.gov/pubmed/30241275
http://dx.doi.org/10.1200/JGO.17.00216

Ejemplares similares